{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T05:49:01Z","timestamp":1776059341056,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-026-04061-3","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T05:05:29Z","timestamp":1776056729000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Anatomic and functional outcomes of intravitreal faricimab for polypoidal choroidal vasculopathy: a review"],"prefix":"10.1007","volume":"46","author":[{"given":"Chia-Wei","family":"Chang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei-Kang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai-Chun","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hung-Chi","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Horng-Jiun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel Yu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng-Wei","family":"Lo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuo-Jen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsien-Chung","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yo-Chen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,13]]},"reference":[{"key":"4061_CR1","doi-asserted-by":"publisher","first-page":"576","DOI":"10.3928\/15428877-20091030-07","volume":"40","author":"YC Chang","year":"2009","unstructured":"Chang YC, Wu WC (2009) Polypoidal choroidal vasculopathy in Taiwanese patients. Ophthalmic Surg Lasers Imaging 40:576\u2013581","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"4061_CR2","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.ophtha.2017.11.019","volume":"125","author":"CMG Cheung","year":"2018","unstructured":"Cheung CMG, Lai TYY, Ruamviboonsuk P, Chen SJ, Chen Y, Freund KB et al (2018) Polypoidal choroidal vasculopathy: definition, pathogenesis, diagnosis, and management. Ophthalmology 125:708\u2013724","journal-title":"Ophthalmology"},{"key":"4061_CR3","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1097\/IAE.0b013e31824f91e8","volume":"32","author":"A Koh","year":"2012","unstructured":"Koh A, Lee WK, Chen LJ, Chen SJ, Hashad Y, Kim H et al (2012) EVEREST study: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy. Retina 32:1453\u20131464","journal-title":"Retina"},{"key":"4061_CR4","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1001\/jamaophthalmol.2018.1804","volume":"136","author":"WK Lee","year":"2018","unstructured":"Lee WK, Iida T, Ogura Y, Chen SJ, Wong TY, Mitchell P et al (2018) Efficacy and safety of intravitreal aflibercept for polypoidal choroidal vasculopathy in the PLANET study: a randomized clinical trial. JAMA Ophthalmol 136:786\u2013793","journal-title":"JAMA Ophthalmol"},{"key":"4061_CR5","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.ophtha.2024.02.014","volume":"131","author":"AM Khanani","year":"2024","unstructured":"Khanani AM, Kotecha A, Chang A, Chen SJ, Chen Y, Guymer R et al (2024) TENAYA and LUCERNE: two-year results from the phase 3 neovascular age-related macular degeneration trials of faricimab with treat-and-extend dosing in year 2. Ophthalmology 131:914\u2013926","journal-title":"Ophthalmology"},{"key":"4061_CR6","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1007\/s00417-015-2933-2","volume":"253","author":"CM Cheung","year":"2015","unstructured":"Cheung CM, Yang E, Lee WK, Lee GK, Mathur R, Cheng J et al (2015) The natural history of polypoidal choroidal vasculopathy: a multi-center series of untreated Asian patients. Graefes Arch Clin Exp Ophthalmol 253:2075\u20132085","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"4061_CR7","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1167\/iovs.16-20575","volume":"58","author":"L Ma","year":"2017","unstructured":"Ma L, Brelen ME, Tsujikawa M, Chen H, Chu WK, Lai TY et al (2017) Identification of ANGPT2 as a new gene for neovascular age-related macular degeneration and polypoidal choroidal vasculopathy in the Chinese and Japanese populations. Invest Ophthalmol Vis Sci 58:1076\u20131083","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4061_CR8","doi-asserted-by":"publisher","first-page":"507","DOI":"10.2147\/OPTH.S448507","volume":"18","author":"H Tanaka","year":"2024","unstructured":"Tanaka H, Hatsukawa Y, Tsuchikawa T, Ueda-Arakawa N, Tamura H, Miyata M et al (2024) Short-term outcomes of 3 monthly intravitreal faricimab on different subtypes of neovascular age-related macular degeneration. Clin Ophthalmol 18:507\u2013516","journal-title":"Clin Ophthalmol"},{"key":"4061_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/srep16204","volume":"5","author":"M Miyake","year":"2015","unstructured":"Miyake M, Ooto S, Yamashiro K et al (2015) Pachychoroid neovasculopathy and age-related macular degeneration. Sci Rep 5:16204","journal-title":"Sci Rep"},{"key":"4061_CR10","doi-asserted-by":"publisher","first-page":"468","DOI":"10.3341\/kjo.2023.0085","volume":"37","author":"S Park","year":"2023","unstructured":"Park S, Lee J, Park JB, Kim ES, Yu SY, Kang MS et al (2023) Diagnosing polypoidal choroidal vasculopathy using color fundus photography, optical coherence tomography, and optical coherence tomography angiography. Korean J Ophthalmol 37:468\u2013476","journal-title":"Korean J Ophthalmol"},{"key":"4061_CR11","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1111\/aos.14295","volume":"98","author":"J\u00d8 S\u00f8rensen","year":"2020","unstructured":"S\u00f8rensen J\u00d8, Subhi Y, Molbech CR, Krogh Nielsen M, S\u00f8rensen TL (2020) Plasma levels of inflammatory chemokines in patients with polypoidal choroidal vasculopathy. Acta Ophthalmol 98:384\u2013389","journal-title":"Acta Ophthalmol"},{"key":"4061_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-35759-4","volume":"13","author":"R Mukai","year":"2023","unstructured":"Mukai R, Kataoka K, Tanaka K, Miyara Y, Maruko I, Nakayama M et al (2023) Three-month outcomes of faricimab loading therapy for wet age-related macular degeneration in Japan. Sci Rep 13:8747","journal-title":"Sci Rep"},{"key":"4061_CR13","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.1007\/s00417-023-06116-y","volume":"261","author":"H Matsumoto","year":"2023","unstructured":"Matsumoto H, Hoshino J, Nakamura K, Nagashima T, Akiyama H (2023) Short-term outcomes of intravitreal faricimab for treatment-na\u00efve neovascular age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 261:2945\u20132952","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"4061_CR14","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00417-023-06241-8","volume":"262","author":"M Maruyama-Inoue","year":"2024","unstructured":"Maruyama-Inoue M, Yanagi Y, Inoue T, Kadonosono K (2024) Comparison of functional and morphologic changes between brolucizumab and faricimab in neovascular age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 262:589\u2013599","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"4061_CR15","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3390\/jcm13020385","volume":"13","author":"C Hara","year":"2024","unstructured":"Hara C, Suzue M, Fujimoto S, Fukushima Y, Sayanagi K, Nishida K et al (2024) (2024) Comparison of loading dose between Aflibercept and Faricimab for Neovascular age-related macular degeneration. J Clin Med 13:385","journal-title":"J Clin Med"},{"key":"4061_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fopht.2024.1509065","volume":"4","author":"N Gilead","year":"2024","unstructured":"Gilead N, Chong YJ, Ibrahim FNI, Sun C, Teo KYC, Cheung CMG (2024) Unexpected retinal fluid compartment responses with anti-VEGF therapy in polypoidal choroidal vasculopathy: a case report of four patients. Front Ophthalmol 4:1509065","journal-title":"Front Ophthalmol"},{"key":"4061_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fopht.2023.1346322","volume":"3","author":"FNI Ibrahim","year":"2024","unstructured":"Ibrahim FNI, Teo KYC, Tan TE, Chan HH, Chandrasekaran PR, Lee SY et al (2024) Initial experiences of switching to faricimab for neovascular age-related macular degeneration and polypoidal choroidal vasculopathy in an Asian population. Front Ophthalmol 3:1346322","journal-title":"Front Ophthalmol"},{"key":"4061_CR18","doi-asserted-by":"publisher","DOI":"10.1177\/24741264241271739","author":"J Bloom","year":"2024","unstructured":"Bloom J, Madani R, Haidar AJ, Alasil T (2024) Faricimab treatment of polypoidal choroidal vasculopathy resistant to intravitreal ranibizumab injections and ranibizumab port delivery (Susvimo). J Vitreoretin Dis. https:\/\/doi.org\/10.1177\/24741264241271739","journal-title":"J Vitreoretin Dis"},{"key":"4061_CR19","first-page":"476","volume":"14","author":"A Machida","year":"2024","unstructured":"Machida A, Oishi A, Ikeda J, Kurihara J, Yoneda A, Tsuiki E et al (2024) Factors associated with success of switching to faricimab for neovascular age-related macular degeneration refractory to intravitreal aflibercept. Life (Basel) 14:476","journal-title":"Life (Basel)"},{"key":"4061_CR20","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1097\/IAE.0000000000002384","volume":"40","author":"JH Cho","year":"2020","unstructured":"Cho JH, Park Y, Cho SC, Ryoo NK, Cho KH, Park SJ et al (2020) Posttreatment polyp regression and risk of massive submacular hemorrhage in eyes with polypoidal choroidal vasculopathy. Retina 40:468\u2013476","journal-title":"Retina"},{"key":"4061_CR21","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1097\/IAE.0000000000001872","volume":"38","author":"TD Lorentzen","year":"2018","unstructured":"Lorentzen TD, Subhi Y, S\u00f8rensen TL (2018) Prevalence of polypoidal choroidal vasculopathy in white patients with exudative age-related macular degeneration: systematic review and meta-analysis. Retina 38:2363\u20132371","journal-title":"Retina"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-026-04061-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-026-04061-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-026-04061-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T05:05:29Z","timestamp":1776056729000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-026-04061-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,13]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4061"],"URL":"https:\/\/doi.org\/10.1007\/s10792-026-04061-3","relation":{},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,13]]},"assertion":[{"value":"2 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article is a narrative review based on previously published literature. As it does not involve any original human or animal research, collection of individual patient data, or clinical interventions, ethical approval and informed consent were not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"205"}}